A series of 2-methyl-5-nitrobenzenesulfonohydrazides were prepared and evaluated as inhibitors of PI3K. An isoquinoline derivative shows good selectivity for the p110alpha isoform over p110beta and p110delta, and also demonstrates good in vitro activity in a cell proliferation assay. Molecular modelling provides a rationalisation for the observed SAR.
|Pages (from-to)||7677 - 7687|
|Number of pages||11|
|Journal||Bioorganic & Medicinal Chemistry|
|Publication status||Published - 2007|